[LCID Study Number: 2018-039WIRB]
An Observational Cohort Study of the Use of Avatrombopag in patients with Thrombocytopenia Associates with Chronic Liver Disease Undergoing a Procedure
The primary objective of this study is to observe the treatment patterns and effects of avatrombopag use in patients with thromobocytopenia associated with chronic liver disease undergoing a procedure. All treatment decisions and clinical assessments will be at the discretion of the treating physician per routine medical care.
Primary Contact Email: [email protected]
Primary Contact Phone: 781-744-3025